Ronald Hinson

Array ( [id] => 2830084 [patent_doc_number] => 05128355 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-07-07 [patent_title] => 'Treatment of congestive heart failure with angiotensin 11 receptor blocking imidazoles' [patent_app_type] => 1 [patent_app_number] => 7/435869 [patent_app_country] => US [patent_app_date] => 1989-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 79451 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1486 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/128/05128355.pdf [firstpage_image] =>[orig_patent_app_number] => 435869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2707498 [patent_doc_number] => 05013761 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-05-07 [patent_title] => 'Serotonin antagonists' [patent_app_type] => 1 [patent_app_number] => 7/434137 [patent_app_country] => US [patent_app_date] => 1989-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3199 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/013/05013761.pdf [firstpage_image] =>[orig_patent_app_number] => 434137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2670362 [patent_doc_number] => 05034415 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-07-23 [patent_title] => 'Treatment of diabetes mellitus' [patent_app_type] => 1 [patent_app_number] => 7/428421 [patent_app_country] => US [patent_app_date] => 1989-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5060 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/034/05034415.pdf [firstpage_image] =>[orig_patent_app_number] => 428421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2710183 [patent_doc_number] => 05017611 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-05-21 [patent_title] => 'Ethyl-3-(2-ethyl-2,2-dimethylhydrazinium)-propionate salts to treat arrhythmia' [patent_app_type] => 1 [patent_app_number] => 7/428901 [patent_app_country] => US [patent_app_date] => 1989-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4892 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/017/05017611.pdf [firstpage_image] =>[orig_patent_app_number] => 428901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2748846 [patent_doc_number] => 05037848 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-08-06 [patent_title] => 'Aryl-cycloalkyl-alkanolamines for treatment of epilepsy' [patent_app_type] => 1 [patent_app_number] => 7/398753 [patent_app_country] => US [patent_app_date] => 1989-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6916 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/037/05037848.pdf [firstpage_image] =>[orig_patent_app_number] => 398753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2801985 [patent_doc_number] => 05124340 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-06-23 [patent_title] => 'Use of calcium channel blocker to prevent cocaine induced craving and reinforcement' [patent_app_type] => 1 [patent_app_number] => 7/372607 [patent_app_country] => US [patent_app_date] => 1989-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 4615 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/124/05124340.pdf [firstpage_image] =>[orig_patent_app_number] => 372607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2768012 [patent_doc_number] => 05036057 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-07-30 [patent_title] => 'Method of treating gastroesophageal reflux' [patent_app_type] => 1 [patent_app_number] => 7/370111 [patent_app_country] => US [patent_app_date] => 1989-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2507 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/036/05036057.pdf [firstpage_image] =>[orig_patent_app_number] => 370111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2883697 [patent_doc_number] => 05109026 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-04-28 [patent_title] => '2-component immunoadjuvant' [patent_app_type] => 1 [patent_app_number] => 7/335088 [patent_app_country] => US [patent_app_date] => 1989-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3924 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/109/05109026.pdf [firstpage_image] =>[orig_patent_app_number] => 335088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2744062 [patent_doc_number] => 05011834 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-04-30 [patent_title] => 'PCP receptor ligands and the use thereof' [patent_app_type] => 1 [patent_app_number] => 7/337858 [patent_app_country] => US [patent_app_date] => 1989-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10499 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 441 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/011/05011834.pdf [firstpage_image] =>[orig_patent_app_number] => 337858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2733828 [patent_doc_number] => 05032585 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-07-16 [patent_title] => 'Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy' [patent_app_type] => 1 [patent_app_number] => 7/323671 [patent_app_country] => US [patent_app_date] => 1989-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 20094 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/032/05032585.pdf [firstpage_image] =>[orig_patent_app_number] => 323671 [rel_patent_id] =>[rel_patent_doc_number] =>)